Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mycolic acid biosynthesis pathway is a critical metabolic route in mycobacteria, notably *Mycobacterium tuberculosis*, responsible for producing mycolic acids—alpha-alkyl, beta-hydroxy long-chain fatty acids that are essential components of the bacterial cell wall. These unique lipids contribute to the impermeability and resilience of the cell envelope, playing a key role in virulence and intrinsic resistance to many antibiotics.
Inhibition of enzymes involved in mycolic acid synthesis, leading to cell wall disruption and bacterial death
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycolic Acid Biosynthesis Pathway.